(Q44679401)

5 December 2017

title

c-CBL is not required for leukemia induction by Bcr-Abl in mice (English)

1 reference

5 December 2017

1 reference

9

1 reference

5 December 2017

Lisa J Wood

2

0 references

author name string

Daniela M Dinulescu

1

1 reference

5 December 2017

Lei Shen

3

1 reference

5 December 2017

Marc Loriaux

4

1 reference

5 December 2017

Christopher L Corless

5

1 reference

5 December 2017

Alec W Gross

6

1 reference

5 December 2017

Ruibao Ren

7

1 reference

5 December 2017

Michael W N Deininger

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

22

1 reference

5 December 2017

issue

55

1 reference

5 December 2017

page(s)

8852-8860

1 reference

SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Suppression of apoptosis induced by growth factor withdrawal by an oncogenic form of c-Cbl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Altered thymic positive selection and intracellular signals in Cbl-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Evidence that the Abelson virus protein functions in vivo as a protein kinase that phosphorylates tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Abl kinase but not PI3-kinase links to the cytoskeletal defects in Bcr-Abl transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

The molecular genetics of Philadelphia chromosome-positive leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Signal transduction pathways involved in BCR-ABL transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206892

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206892

1 reference

release_4gmtr3vsjvg77lagkg32kkaopu

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4gmtr3vsjvg77lagkg32kkaopu

24 November 2022

mapped directly with Wikidata item

1 reference